Antonio Pardo
YOU?
Author Swipe
View article: Competencias y epistemología de la formación posgradual en psicología. Una revisión desde sus campos aplicados
Competencias y epistemología de la formación posgradual en psicología. Una revisión desde sus campos aplicados Open
Este libro explora las vías de formalización de la formación posgradual en Colombia y el estrecho vínculo de las rutas curriculares con las competencias en estos campos. Los capítulos son un cuadro histórico abierto que brinda al lector un…
View article: Comparison of false positive and false negative rates of two indices of individual reliable change: Jacobson-Truax and Hageman-Arrindell methods
Comparison of false positive and false negative rates of two indices of individual reliable change: Jacobson-Truax and Hageman-Arrindell methods Open
Background Quantification of change is crucial for correctly estimating the effect of a treatment and for distinguishing random or non-systematic changes from substantive changes. The objective of the present study was to learn about the p…
View article: Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day
Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day Open
Objective: To evaluate the treatment effect size throughout the day of amphetamine extended-release oral suspension (AMPH EROS; Tris Pharma, Inc., Monmouth Junction, NJ, USA) in a laboratory classroom study conducted in child…
View article: Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of the Amphetamine Extended-Release Tablet in Adults with Attention-Deficit/Hyperactivity Disorder
Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of the Amphetamine Extended-Release Tablet in Adults with Attention-Deficit/Hyperactivity Disorder Open
Background Attention-deficit/hyperactivity disorder (ADHD) is a neurobehavioral disorder characterized by pervasive impairment in symptoms of inattention, hyperactivity, and impulsivity. Psychopharmacologic treatment is targeted at the man…
View article: Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD
Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD Open
The positive palatability data presented here will be useful for future "real-world" assessments of adherence to treatment with the AMPH ER TAB. Enhanced adherence may bolster the argument that taste, mouthfeel, and aftertaste are critical…
View article: Cardiovascular Risk Management Recommendations for Patients with Chronic Myeloid Leukaemia who are Candidates for Ponatinib: Multidisciplinary Delphi Analysis
Cardiovascular Risk Management Recommendations for Patients with Chronic Myeloid Leukaemia who are Candidates for Ponatinib: Multidisciplinary Delphi Analysis Open
Progress in the treatment of Chronic Myeloid Leukaemia (CML) has significantly improved the survival rates and prognosis of these patients. As a result, there is a growing awareness of the adverse effects that the treatments used can have …
View article: Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in 6–12-Year-Old Children with ADHD
Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in 6–12-Year-Old Children with ADHD Open
Methods This Phase 1, open-label, single-dose, one-period, one-treatment PK study enrolled 12 children 6–12 y with ADHD. PK parameters for d- and l-amphetamine in plasma (Cmax, tmax, AUC0–8, and t1/2) were calculated and expressed as means…
View article: Comparative Bioavailability of Amphetamine Extended-Release Oral Suspension and Extended-Release Mixed Amphetamine Salts
Comparative Bioavailability of Amphetamine Extended-Release Oral Suspension and Extended-Release Mixed Amphetamine Salts Open
Purpose This open-label, single-dose, randomized, two-period, two-treatment, two-sequence, crossover study evaluated the comparative bioavailability between amphetamine extended-release oral suspension (treatment A: AMPH EROS, Dyanavel XR …
View article: Change in the center of the distribution and in the individual scores: Relation with heteroskedastic pre- and post-test distributions
Change in the center of the distribution and in the individual scores: Relation with heteroskedastic pre- and post-test distributions Open
(1) In the absence of information about the PIC, the ES may be used to estimate this percentage. (2) The PIC is useful in interpreting the meaning of ES measures.
View article: 178 Single-Dose Pharmacokinetics of Amphetamine Extended-Release Tablet Compared with Amphetamine Extended-Release Oral Suspension
178 Single-Dose Pharmacokinetics of Amphetamine Extended-Release Tablet Compared with Amphetamine Extended-Release Oral Suspension Open
Objectives: Evaluate comparative bioavailability of single-dose amphetamine extended-release tablet (AMPH ER TAB, Tris Pharma, Inc., Monmouth Junction, NJ) 20 mg, swallowed whole or chewed and amphetamine extended-release oral suspension (…
View article: 179 Palatability Assessment of a New Amphetamine Extended-Release Tablet Formulation
179 Palatability Assessment of a New Amphetamine Extended-Release Tablet Formulation Open
Background: In 2016, the US FDA issued an industry guidance document “Quality Attribute Considerations for Chewable Tablets” which describes the quality attributes to be considered when developing chewable tablets. It includes recommendati…
View article: Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension
Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension Open
Objective Evaluate the relative bioavailability of single-dose amphetamine extended-release tablet (AMPH ER TAB) 20 mg, swallowed whole or chewed, and amphetamine extended-release oral suspension (AMPH EROS) 2.5 mg/mL; evaluate food effect…
View article: �ndice de calcificaci�n coronaria en la tomograf�a computarizada para predecir la necesidad de aterectom�a rotacional
�ndice de calcificaci�n coronaria en la tomograf�a computarizada para predecir la necesidad de aterectom�a rotacional Open
RESUMEN Introducción y objetivos: El objetivo del estudio fue investigar si la evaluación no invasiva del índice de calcificación coronaria mediante tomografía computarizada cardiaca multidetector (TCMD) puede predecir la necesidad de una …
View article: Coronary artery calcium score with cardiac computed tomography to anticipate the need for rotational atherectomy
Coronary artery calcium score with cardiac computed tomography to anticipate the need for rotational atherectomy Open
Introduction and objectives: This study aims to investigate if the non-invasive assessment of coronary calcium score using multislice cardiac computerized tomography (MSCT) may anticipate the need for elective rotational atherectomy (RA) d…
View article: 32 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
32 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder Open
Objective To determine whether amphetamine extended-release oralsuspension (AMPH EROS) has an onset of effect at 30minutes postdose inchildren with ADHD. Methods This randomized, double-blind, 2-treatment, 2-sequence, placebo-controlled cr…
View article: 87 Efficacy Measures in an Open-label Dose-Optimization of an Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder
87 Efficacy Measures in an Open-label Dose-Optimization of an Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder Open
Objectives Report the efficacy of open-label amphetamine extended-release oral suspension (AMPH EROS) for the treatment of children with ADHD. AMPH EROS has a 1-hr onset of effect and a duration of action of 13hours and was approved by FDA…
View article: 89 A Novel, Modified-Release Drug Delivery Technology Containing Amphetamine-Ion Exchange Complexes
89 A Novel, Modified-Release Drug Delivery Technology Containing Amphetamine-Ion Exchange Complexes Open
The proprietary immediate and extended drug delivery technology LiquiXR™ utilizes an ion-exchange resin that complexes with amphetamine or any other active moiety that can be protonated and is water-soluble. The active drug product forms a…
View article: 31 A Modified-Release Drug Delivery Technology Containing Amphetamine-Ion Exchange Complexes
31 A Modified-Release Drug Delivery Technology Containing Amphetamine-Ion Exchange Complexes Open
The proprietary, immediate and extended drug delivery technologyLiquiXR® utilizes an ion-exchange resin that complexes with amphetamine or any active moiety that can be protonated and is water-soluble. The active ingredient of the drug pro…
View article: 88 The Efficacy and Safety of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in Children with Attention-Deficit/Hyperactivity Disorder
88 The Efficacy and Safety of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in Children with Attention-Deficit/Hyperactivity Disorder Open
OBJECTIVES To determine the efficacy and safety of amphetamine extended-release oral suspension (AMPH EROS) in the treatment of attention-deficit/hyperactivity disorder (ADHD) compared with placebo in a dose-optimized, randomized, double-b…
View article: Statistics for Evaluating Pre-post Change: Relation Between Change in the Distribution Center and Change in the Individual Scores
Statistics for Evaluating Pre-post Change: Relation Between Change in the Distribution Center and Change in the Individual Scores Open
In a number of scientific fields, researchers need to assess whether a variable has changed between two time points. Average-based change statistics (ABC) such as Cohen's d or Hays' ω2 evaluate the change in the di…
View article: Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder Open
AMPH EROS was effective in reducing ADHD symptoms at 30 minutes postdose as indicated by SKAMP-C score improvement, although improvements in PERMP scores at 30 minutes were not statistically significant. AEs were mild or moderate and consi…
View article: LEWIN, ROGER, Complexity: Life at the edge of chaos, Macmillan, New York, 1992, 208 págs.
LEWIN, ROGER, Complexity: Life at the edge of chaos, Macmillan, New York, 1992, 208 págs. Open
View article: Ruelle, David: Azar y caos, Alianza, Madrid, 1993, 202 págs.
Ruelle, David: Azar y caos, Alianza, Madrid, 1993, 202 págs. Open
View article: Kordon, Claude: El lenguaje de las células, Alianza, Madrid, 1994, 107 págs.
Kordon, Claude: El lenguaje de las células, Alianza, Madrid, 1994, 107 págs. Open
View article: CAVALLI-SFORZA, LUCA Y FRANCESCO, Quiénes somos. Historia de la diversidad humana, Crítica, Barcelona, 1994, 309 págs.
CAVALLI-SFORZA, LUCA Y FRANCESCO, Quiénes somos. Historia de la diversidad humana, Crítica, Barcelona, 1994, 309 págs. Open
conocido por sus estudios de genética de poblaciones humanas, intenta poner al alcance del gran público sus conocimientos de genética humana, con la colaboración de su hijo Francesco, que ha contribuido a dar a la obra el estilo ameno y as…
View article: RESCHER, NICHOLAS, Los límites de la ciencia, Tecnos, Madrid, 1994, 255 págs.
RESCHER, NICHOLAS, Los límites de la ciencia, Tecnos, Madrid, 1994, 255 págs. Open
View article: Xavier THÉVENOT, La bioética, Ed. Mensajero, Bilbao 1990, 150 pp., 13,5 x 21.
Xavier THÉVENOT, La bioética, Ed. Mensajero, Bilbao 1990, 150 pp., 13,5 x 21. Open
como ya se está demostrando en Holanda.
View article: Augusto SARMIENTO, Gregorio RUIZ-PÉREZ y Juan Carlos MARTÍN, Ética y genética, Ediciones Universidad de Navarra, S. A., Pamplona 1993, 221 pp., 16 x 24.
Augusto SARMIENTO, Gregorio RUIZ-PÉREZ y Juan Carlos MARTÍN, Ética y genética, Ediciones Universidad de Navarra, S. A., Pamplona 1993, 221 pp., 16 x 24. Open
View article: Andreas LAUN, La conciencia, Barcelona 1993, «Ediciones Internacionales Universitarias, S. A.», 114 pp., 17 x 24.
Andreas LAUN, La conciencia, Barcelona 1993, «Ediciones Internacionales Universitarias, S. A.», 114 pp., 17 x 24. Open
View article: Mariano ARTIGAS, Las fronteras del evolucionismo, Ed. Palabra, Madrid 1991, 206 pp. 13,5 x 20 cm.; El hombre a la luz de la ciencia, Palabra, Madrid 1992, 254 pp. 13,5 x 20; Ciencia, razón y fe, Ed. Palabra, Madrid 1992, 198 pp. 13,5 x 20.
Mariano ARTIGAS, Las fronteras del evolucionismo, Ed. Palabra, Madrid 1991, 206 pp. 13,5 x 20 cm.; El hombre a la luz de la ciencia, Palabra, Madrid 1992, 254 pp. 13,5 x 20; Ciencia, razón y fe, Ed. Palabra, Madrid 1992, 198 pp. 13,5 x 20. Open